Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Trump wants faster FDA action, but 1 in 3 drugs have safety issues after approval
Trump wants faster FDA action, but 1 in 3 drugs have safety issues after approval
Trump wants faster FDA action, but 1 in 3 drugs have safety issues after approval
Submitted by
admin
on May 9, 2017 - 10:41pm
Source:
Stat
News Tags:
Donald Trump
FDA
drug safety
drug approvals
Headline:
Trump wants faster FDA action, but 1 in 3 drugs have safety issues after approval
Do Not Allow Advertisers to Use My Personal information
